Shares of abrdn Healthcare Investors (NYSE:HQH – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $24.67 and last traded at $24.5660, with a volume of 51189 shares trading hands. The stock had previously closed at $23.98.
abrdn Healthcare Investors Stock Down 3.4%
The stock has a fifty day moving average of $21.78 and a 200 day moving average of $20.08.
abrdn Healthcare Investors Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Monday, August 24th will be given a dividend of $0.66 per share. The ex-dividend date is Monday, August 24th. This represents a $2.64 annualized dividend and a dividend yield of 11.1%.
Institutional Trading of abrdn Healthcare Investors
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Further Reading
- Five stocks we like better than abrdn Healthcare Investors
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
